arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

GYRE THERAPEUTICS, INC.

GYRE

$6.65 ▲ +0.24 (+3.74%) at close

18 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

GYRE THERAPEUTICS, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $594.1M

Dividend Yield —

Revenue Growth 10.2% ↗

Op. Margin 9.9% ↘

ROIC 7.4% ↘

FCF / Share $-0.00 ↗

Trailing P/E 110.8x

Price / Book 5.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$116.59M

↑ +10.2% —

Net Income Profit after all expenses

$9.88M

↓ -44.8% —

Operating Margin Operating profit as % of sales

9.9%

↓ -35.5% 56th

FCF / Share Free cash flow per share

$-0.00

↑ +97.1% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

Health Breakdown

Profitability ↑

Returns

Cash Quality

Dividend History

Dividend / share · sourced from SEC filings

$0.24 Latest / share

-83.2% YoY

Q2 FY2022

$1.43

Q3 FY2022

Q4 FY2022

$0.24

Q1 FY2023

Q2 FY2023

Q3 FY2023

Q4 FY2023

Q1 FY2024

Q2 FY2024

Q3 FY2024

Q4 FY2024

Q1 FY2025

Q2 FY2025

Q3 FY2025

Q4 FY2025

Q1 FY2026

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	10.2% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+28%)	-6.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-185%)	10.9% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+36%)	—	—	—	—	-99.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1343%)	—	—	—	-92.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1255%)	-93.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1272%)	-40.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-609%)	13.9% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+74%)	242.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2925%)	—	—
EPS Growth YoY (%)	-57.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	—	—	—	—	—	—	—	—	—	22.2% Good Good Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—
Net Income Growth YoY (%)	-44.8% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	-56.4% Weak ↓ Weak Declining Year-over-year change in net income	-1.9% Weak ↑ Weak Improving Year-over-year change in net income	-83.6% Weak ↓ Weak Declining Year-over-year change in net income	-39.4% Weak ↓ Weak Declining Year-over-year change in net income	-27.2% Weak ↓ Weak Declining Year-over-year change in net income	-14.8% Weak ↑ Weak Improving Year-over-year change in net income	54.7% Excellent ↑ Excellent Improving Year-over-year change in net income	30.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-567.4% Weak Weak Year-over-year change in net income	18.0% Good Good Year-over-year change in net income	N/M	N/M	—	—
FCF Growth YoY (%)	97.1% Excellent Excellent Year-over-year change in free cash flow	N/M	194.8% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—	—	—	—	28.3% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	—	—
Revenue CAGR 3Y (%)	4.5% Caution Caution Compound annual revenue growth over 3 years	—	75.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	174.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	54.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	-85.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-65.1% Weak Weak Compound annual revenue growth over 3 years	32.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	41.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	—	616.7% Excellent Excellent Compound annual revenue growth over 5 years	151.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	-72.2% Weak Weak Compound annual revenue growth over 5 years	-55.4% Weak Weak Compound annual revenue growth over 5 years	—	—	-59.4% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	14.5% Good Good Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	9.9% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-34%)	15.3% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-59.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-495%)	9.0% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-40%)	—	-273.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1926%)	—	—	—	—	—	—	—	-14.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-194%)	-10.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-167%)	15.3% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-160.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1173%)	—
Effective Tax Rate (%) (%)	31.6% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	22.9% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-11.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	54.2% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	8.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-29%)	16.9% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+41%)	-75.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-728%)	4.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-65%)	—	-268.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2337%)	—	—	—	—	—	—	—	-12.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-201%)	-8.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-173%)	12.7% Fair Fair Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+6%)	-157.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1410%)	—
FCF Margin (%) (%)	-0.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-5.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	15.3% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	5.6% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	-262.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	-111.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-87.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	157.5% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-97.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.33x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.32x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	9.23x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	9.98x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	12.39x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	7.4% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	19.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	471.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	9.9% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-169.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-59.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-56.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-100.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	11.1% Good Good Return earned on debt + equity capital invested Optimal: > 10%	-46.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	6.9% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	12.9% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-57.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	10.9% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-157.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-60.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-55.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-53.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	5.0% Caution Caution Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	9.3% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-38%)	28.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+88%)	—	10.1% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-32%)	-214.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1527%)	-73.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-593%)	-80.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-638%)	-25.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-267%)	-70.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-567%)	-105.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-803%)	-47.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-413%)	-29.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	-34.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-331%)	-4.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-4.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	11.9% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-21%)	-57.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-481%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	-9.34x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1291.91x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-890.87x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-94.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-73.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	85.72x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	-185.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-37.07M	$-11.81M	$-33.51M	$-25.18M	$-44.35M	$-30.36M	$-15.37M	$-31.21M	$-14.47M	$-10.26M	$-29.10M	$-56.43M	$-53.35M	$-80.25M	$-105.30M	$-164.50M	$-83.91M	$-51.20M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.34x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.27x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.09x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$1.30	$1.24	$1.72	$1.61	—	—	—	—	—	—	—	—	—	$1.73	$3.09	$3.00	$0.98	—
Basic EPS, GAAP (USD)	$0.06	$0.14	$-1.41	$0.04	$-2.87	—	—	—	—	—	—	—	—	$-0.21	$-0.27	$0.38	$-1.54	—
Free Cash Flow per Share (USD)	$-0.00	$-0.07	$0.26	$0.09	$-2.76	—	—	—	—	—	—	—	—	$-1.93	$-2.69	$4.73	$-0.95	—
Book Value per Share (USD)	$1.16	$0.73	$-0.21	$0.67	$1.31	$3.44	$5.68	$10.03	$5.06	$20.04	$41.24	$3.23	$3.99	$5.23	$5.22	$3.18	$2.69	—
Tangible Book Value per Share (USD)	$1.16	$0.73	$-0.21	$0.67	$1.31	$3.44	$5.68	$10.03	$5.06	$20.04	$41.24	$3.23	$3.99	$5.23	$5.22	$3.18	$2.69	—
Basic Weighted Avg Shares (shares)	89.34M	85.09M	65.83M	63.59M	30.64M	—	—	—	—	—	—	—	—	33.48M	31.64M	28.54M	25.64M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$84.08M	$45.27M	$37.17M	$37.41M	$37.31M	$71.71M	$67.17M	$119.19M	$30.37M	$15.56M	$30.94M	$105.23M	$82.63M	$116.39M	$119.61M	$119.42M	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	$0.00	$1.14M	$1.99M	$1.99M	$1.35M	—	—
Total Equity (USD)	$106.03M	$63.32M	$-15.83M	$42.52M	$41.09M	$76.07M	$68.34M	$119.94M	$30.77M	$16.07M	$31.43M	$109.08M	$134.61M	$175.91M	$174.29M	$91.85M	$68.99M	$57.37M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$116.59M	$105.76M	$113.45M	$102.29M	—	$20.95M	—	$6.00K	$1.02M	—	—	$275.00K	$3.63M	$57.86M	$97.64M	$85.71M	$25.06M	—
Depreciation Expense (USD)	$2.48M	$1.55M	$1.07M	$1.09M	$290.00K	$138.00K	$146.00K	$149.00K	$173.00K	$389.00K	$470.00K	$351.00K	$547.00K	$2.21M	$2.48M	$2.00M	$1.83M	—
Net Income, GAAP (USD)	$9.88M	$17.90M	$-85.48M	$4.31M	$-87.93M	$-56.24M	$-55.18M	$-30.05M	$-21.56M	$-16.95M	$-14.76M	$-32.62M	$-46.70M	$-7.00M	$-8.53M	$10.90M	$-39.40M	—
Operating Cash Flow (USD)	$1.01M	$-3.64M	$25.89M	$10.68M	$-83.75M	$-55.05M	$-43.61M	$-28.55M	$-19.94M	—	—	—	$-40.61M	$-64.24M	$-83.72M	$138.30M	$-24.27M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

GYRE THERAPEUTICS, INC.

Analytical Summary

18-Year Financial Trajectory

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare GYRE with peers